Cited by

• Identifying Attributes That Influence In Vitro-to-In Vivo Concordance by Comparing In Vitro Tox21 Bioactivity Versus In Vivo DrugMatrix Transcriptomic Responses Across 130 Chemicals.

  Klaren WD, Ring C, Harris MA, Thompson CM, Borghoff S, Sipes NS, Hsieh JH, Auerbach SS, Rager JE. Klaren WD, et al. Toxicol Sci. 2019 Jan 1;167(1):157-171. doi: 10.1093/toxsci/kfy220. Toxicol Sci. 2019. PMID: 30202884 Free PMC article.
• The ToxCast pipeline: updates to curve-fitting approaches and database structure.

  Feshuk M, Kolaczkowski L, Dunham K, Davidson-Fritz SE, Carstens KE, Brown J, Judson RS, Paul Friedman K. Feshuk M, et al. Front Toxicol. 2023 Sep 21;5:1275980. doi: 10.3389/ftox.2023.1275980. eCollection 2023. Front Toxicol. 2023. PMID: 37808181 Free PMC article.
• Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates.

  Strickland JD, Martin MT, Richard AM, Houck KA, Shafer TJ. Strickland JD, et al. Arch Toxicol. 2018 Jan;92(1):487-500. doi: 10.1007/s00204-017-2035-5. Epub 2017 Aug 2. Arch Toxicol. 2018. PMID: 28766123 Free PMC article.
• Chemical Mixtures in Household Environments: In Silico Predictions and In Vitro Testing of Potential Joint Action on PPARγ in Human Liver Cells.

  Carberry CK, Turla T, Koval LE, Hartwell H, Fry RC, Rager JE. Carberry CK, et al. Toxics. 2022 Apr 19;10(5):199. doi: 10.3390/toxics10050199. Toxics. 2022. PMID: 35622613 Free PMC article.
• Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates.

  Truong L, Ouedraogo G, Pham L, Clouzeau J, Loisel-Joubert S, Blanchet D, Noçairi H, Setzer W, Judson R, Grulke C, Mansouri K, Martin M. Truong L, et al. Arch Toxicol. 2018 Feb;92(2):587-600. doi: 10.1007/s00204-017-2067-x. Epub 2017 Oct 27. Arch Toxicol. 2018. PMID: 29075892 Free PMC article.